Biotechs and Related Hitting 52-Week Lows Too (BBH, AMGN, AMLN, ARNA, GERN, INGN, PGNX, SUPG)
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Today has been a rough day with more 52-week lows than we can recall in quite some time. The biotechs haven’t been immune. You can even see that the Biotech HOLDRs (BBH) at $160+ are only about 2% above the 52-week lows of $157.95, while the iShares Nasdaq Biotechnology (IBB) ETF at $80.29 is only about half-way in its 52-week trading range of $72.37 to $89.00. The difference is because of the composition.
Here are BIOTECH STOCKS hitting 52-week lows today:
- Amgen (AMGN)
- Amylin Pharma (AMLN)
- Arena Pharma (ARNA)
- Cleveland Biolabs (CBLI)
- Geron (GERN)
- Introgen (INGN)
- Progenics Pharma (PGNX)
- Somaxon Pharma (SOMX)
- Spectrum Pharma (SPPI)
- Supergen (SUPG)
If you wantto see how bad today is look at the master list of 52-week lows we compiled two hours ago with financials, restaurants, retail, REIT, property, tech and more. It’s a huge list.
Jon C. Ogg
January 4, 2008
Contact [email protected] for any questions or corrections.


